Erica Lynne Palmisano, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 3185 Macatawa Dr Sw Ste B, Grandville, MI 49418 Phone: 616-531-6900 |
News Archive
The promising investigational targeted therapy ibrutinib and its mechanism of silencing gene communication pathways critical to the development of cancer may be an effective way to combat chronic lymphocytic leukemia (CLL), according to studies presented today at the 54th Annual Meeting of the American Society of Hematology (ASH).
Iron accumulation in myocardial cells, potentially resulting in heart failure or fatal arrhythmia, is one of the complications most feared by patients with thalassemia major, a hereditary disease also known as Mediterranean anemia.
AARP, the seniors' lobby, has shed as many as 60,000 members in two months over its implicit support for health reform that some members say could lead to Medicare cuts, USA Today reports. The group will launch a campaign next week in hopes of regaining ground with seniors and reestablishing a politically neutral image.
Cancer remains the second-leading cause of death in the United States. This year, an estimated 1.7 million new cases will be diagnosed, with nearly 610,000 people expected to die from the disease, according to the National Cancer Institute.
Boston Scientific Corporation today announced the start of patient enrollment in the EVOLVE clinical trial, which is designed to assess the safety and performance of its fourth-generation SYNERGYâ„¢ Coronary Stent. The first patient was enrolled by Ian Meredith, M.B.B.S., Ph.D., Professor and Director of MonashHeart, at Monash Medical Centre in Melbourne, Australia.
› Verified 2 days ago